Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
about
Design and evaluation of EphrinA1 mutants with cerebral protective effect.TREM2 protects against cerebral ischemia/reperfusion injuryGLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in MiceComparison of surgical methods of transient middle cerebral artery occlusion between rats and mice.The shh signaling pathway is upregulated in multiple cell types in cortical ischemia and influences the outcome of stroke in an animal modelQuantification of neurovascular protection following repetitive hypoxic preconditioning and transient middle cerebral artery occlusion in miceElevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats.Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice.Time course of neuroprotection induced by in vivo normobaric hyperoxia preconditioning and angiogenesis factors.Endothelial proliferation modulates neuron-glia survival and differentiation in ischemic stress.Genetic and pharmacological inhibition of Cdk1 provides neuroprotection towards ischemic neuronal death.Octadecylpropyl Sulfamide Reduces Neurodegeneration and Restores the Memory Deficits Induced by Hypoxia-Ischemia in Mice.A Selective Histamine H Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia
P2860
Q33689614-E43AB07B-445B-4090-9BD4-FBFF19F48E22Q33771678-A3402AB4-C187-4DA9-8A3C-7EAEAD9E93FFQ33780749-C7F11432-8538-4259-99B1-19BA029E09C4Q34990098-872FCB7B-FBC2-4742-A9C1-3D4F093FA12CQ35557757-6594D4FE-A3BD-4219-B2E4-C66C9DF08B98Q35636816-3D611C62-4722-4FB9-BCDC-CF17A40E532DQ37158084-AE5D0F4A-0A78-4261-8FB2-DE18291BEF2BQ41529359-143A091C-7FF2-4EB0-95A1-316502448CBEQ42329875-5A1ADC6C-9B8C-4DF8-9C4D-1F1D03736751Q42402981-A590DB7D-889F-46A0-B49A-F20CFFFACE1AQ52723921-1CE8114E-EE67-4465-AC30-A8BF2E1D87F8Q55100647-4A93D6E2-03DD-422B-B1B3-7C2DC5C60702Q58694870-3C8EBDD8-FDA4-4B72-A029-0B09A7D0D07E
P2860
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@ast
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@en
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@nl
type
label
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@ast
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@en
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@nl
prefLabel
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@ast
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@en
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@nl
P2860
P356
P1476
Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.
@en
P2093
Estelle Rousselet
Jasna Kriz
P2860
P356
10.3791/4038
P577
2012-11-06T00:00:00Z